VITAL ancillary study investigates Vitamin D3 and Omega-3 effects on infection risk and hCAP18 levels
Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)
Abstract
The VITAL ancillary study is assessing if daily vitamin D3 (2000 IU) or omega-3 fatty acids (1 gram) reduce infection risk and modulate hCAP18 in 25,875 adults.